Latest AI and machine learning research in hemophilia for healthcare professionals.
Artificial intelligence (AI) is revolutionizing drug discovery with unprecedented speed and efficien...
Epidermal growth factor receptor (EGFR) is a potential target for anticancer therapies and plays a c...
INTRODUCTION: Although febrile neutropenia (FN) remains a major cause of morbidity and mortality in ...
TAM (TYRO3, AXL, MERTK) receptor tyrosine kinases (RTKs) have intrinsic roles in tumor cell prolifer...
OBJECTIVES: To explore how artificial intelligence (AI) can enhance infodemiology, which distributes...
Focal adhesion kinase (FAK) is a critical drug target implicated in various disease pathways, includ...
Warfarin is a common anticoagulant drug for thrombo-prophylaxis in stroke and venous thromboembolism...
We aimed to investigate the independent outcome predictors of continuous antibiotic prophylaxis (CAP...
Parasitic nematodes represent a substantial global burden, impacting animal health, agriculture and ...
Hand-foot skin reaction (HFSR) is a common adverse effect of vascular endothelial growth factor rece...
P38α has been identified as a key target for drug design to treat a wide range of diseases. In this ...
Colorectal cancer (CRC) is the third most common and second most deadly cancer worldwide. Despite ad...
Targeted therapy with an allosteric inhibitor (AIs) is an important area of research in patients wit...
Homologous recombination deficiency (HRD) is a well-recognized important biomarker in determining th...
BACKGROUND: Immune checkpoint inhibitors (CPIs) have revolutionized cancer therapy for several tumor...
CDK4/6 inhibitors in combination with endocrine therapy are widely used to treat HR+/HER2- metastati...
PURPOSE: Primary barriers to application of immune checkpoint inhibitor (ICI) therapy for cancer inc...
Over 90% of gastrointestinal stromal tumors (GISTs) harbor mutations in KIT or PDGFRA that can predi...
Human organic cation transporter 2 (hOCT2/SLC22A2) is a key drug transporter that facilitates the tr...
BACKGROUND: Selpercatinib, a selective RET kinase inhibitor, is approved for treating various cancer...
Artificial intelligence (AI) is rapidly advancing our ability to identify and interpret genetic vari...